Sudeep Pharma receives FDA approval for its 179 Nandesari greenfield facility
Mumbai, Oct. 26 -- Sudeep Pharma announced that its new pharma greenfield manufacturing facility at 179 Nandesari, Gujarat, has received approval from the Gujarat Food and Drug Control Administration (FDA), authorising the Company to commence manufacturing operations at the site.
Published by HT Digital Content Services with permission from Capital Market....
Click here to read full article from source
To read the full article or to get the complete feed from this publication, please
Contact Us.